A Comparison of Uterine Fibroid Embolization Versus Laparoscopic Myomectomy or Hysterectomy for Symptomatic Uterine Fibroids

2009 ◽  
Vol 16 (6) ◽  
pp. S155-S156
Author(s):  
J.C. Petrozza ◽  
A. Chauhan ◽  
G. Salazar
Keyword(s):  
Uterine Fibroid ◽  
Uterine Fibroids ◽  
Laparoscopic Myomectomy ◽  
Uterine Fibroid Embolization

scholarly journals Title: Long-term health related quality of life following Uterine Fibroid Embolization 1 in a predominantly black African population: A retrospective Cohort study

2021 ◽  
Author(s):  
Marleen Temmerman ◽  
Timona Obura ◽  
Adelaide Lusambili ◽  
Michael Kioko
Keyword(s):  
Quality Of Life ◽  
Uterine Fibroid ◽  
Uterine Fibroids ◽  
Health Related Quality ◽  
Predominantly Black ◽  
Uterine Fibroid Embolization ◽  
Symptom Severity Score ◽  
Related Quality ◽  
Health Related

Abstract Background: Uterine Fibroid Embolization (UFE) is one of the effective options available for treatment of symptomatic uterine fibroids with documented improvement in the quality of life and reduction in symptoms. Most of the studies have demonstrated an improvement in the quality of life over a short to intermediate period. We carried out this study to assess the long-term quality of life following uterine fibroid embolization in a predominantly black population. There are no identified studies locally or in Africa addressing this issue whereas studies done elsewhere indicate a probable increased fibroid disease burden among black women. Methods: This was a retrospective single cohort study that recruited patients who had UFE between 2009-2014. Study participants were sampled consecutively, invited to the study and asked to fill an online general demographic tool and the UFS-QOL. Wilcoxon signed rank tests were done to test for statistical significance between HRQOL scores. Pearson correlation analysis was carried out to evaluate possible association between various independent factors and specific outcomes of interest such as quality of life and symptom severity score. Results: Data was obtained from 77 participants. The median duration after the initial UFE was eight years. The median health related quality of life was 88.6 (62.9-98.3). This was statistically significant from baseline median scores of similar studies. The median symptom severity score decreased from a baseline score of 54.7 (43.8-65.6) to 21.9 (6.3-42.2). This decrease was statistically significant (p-value <0.001). Twenty-four participants (31.1%) reported follow up fibroid treatments after the initial UFE procedure. Eleven participants (14.3%) reported major repeat procedures (myomectomy, hysterectomy and UFE) .Seventeen participants (22%) reported a pregnancy after the UFE procedure with ten participants (13 %) reporting to have had children after the UFE procedure. Conclusion: UFE results in clinically sustained improvement in health related quality of life and symptom control among patients with uterine fibroids.

scholarly journals A Case of Pyomyoma following Uterine Fibroid Embolization and a Review of the Literature

2016 ◽  
Vol 2016 ◽  
pp. 1-5 ◽  
Author(s):  
Chika C. Obele ◽  
Samantha Dunham ◽  
Genevieve Bennett ◽  
Johanna Pagan ◽  
Lok Yun Sung ◽  
...  
Keyword(s):  
Intravenous Administration ◽  
Medical Practice ◽  
Uterine Fibroid ◽  
Surgical Intervention ◽  
Rare Complication ◽  
Uterine Fibroids ◽  
Signs And Symptoms ◽  
Review Of The Literature ◽  
Uterine Fibroid Embolization ◽  
Uterine Infection

Background.Since its introduction in 1996, uterine fibroid embolization (UFE) has become standard medical practice in the management of symptomatic uterine fibroids. An extremely rare complication, pyomyoma, has been reported only 5 times previously in the literature following UFE.Case.A 37-year-old woman underwent UFE for symptomatic leiomyomas of the uterus. Signs and symptoms of uterine infection ensued, beginning at 6 days following the procedure. Recurrent fevers and increasing leukocytosis despite the intravenous administration of appropriate antibiotics eventually necessitated surgical intervention on postprocedure day #18.Conclusion.An extremely rare complication of UFE is herein presented, pyomyoma, with a review of other reported cases. Commonalities are sought among these few reported cases with the hope of increasing diagnostic acumen in the detection of this disease.

Uterine fibroid embolization can still be improved: observations on post-procedure magnetic resonance imaging

2005 ◽  
Vol 46 (5) ◽  
pp. 547-553 ◽  
Author(s):  
E. J. Dorenberg ◽  
Z. Novakovic ◽  
H.-J. Smith ◽  
G. Hafsahl ◽  
J. Å. Jakobsen
Keyword(s):  
Magnetic Resonance Imaging ◽  
Magnetic Resonance ◽  
Contrast Enhancement ◽  
Uterine Fibroid ◽  
Uterine Fibroids ◽  
Resonance Imaging ◽  
Post Contrast ◽  
Uterine Fibroid Embolization ◽  
Uterine Arteries ◽  
Uterine Volume

Purpose: To evaluate the efficacy and completeness of uterine fibroid embolization (UFE) measured by changes in volume and signal intensity at magnetic resonance imaging (MRI), and to compare with clinical outcome. Material and Methods: 40 women with symptomatic uterine fibroids underwent bilateral uterine artery embolization. At MRI studies, including post-contrast sequences before and repeatedly after treatment, the uterus and dominant fibroids were evaluated for volume, location, and contrast enhancement. Prior to treatment, all myomas showed significant contrast enhancement. The mean uterine volume was 929 ml. Clinical examinations with emphasis on menorrhagia, pelvic pain, and urinary dysfunction were performed before and 6 and 12 months after treatment. Results: UFE was bilaterally successful in 38 patients. After UFE, MRI showed no enhancement of myomas in 30 patients. In 8 patients, post-procedural MRI revealed partially remaining vascularization of fibroids despite angiographically complete embolization of the uterine arteries. On average, uterine volume decreased by 46.2% at 12 months. There was significant improvement of symptoms in the majority of patients, but slightly less improvement in patients with partially remaining vascularization of myomas. Conclusion: UFE causes significant volume reduction of myomas and clinical improvement. MRI can reveal remaining vascularization in myomas despite angiographically complete embolization of uterine arteries.

scholarly journals Incidence of amenorrhea and premature ovarian failure in women who underwent uterine fibroid embolization: single centre study

2021 ◽  
Vol 9 (12) ◽  
pp. 489-493
Author(s):  
Tahany Al-Mailo ◽  
Lulwa Abdullah AlTakroni
Keyword(s):  
Uterine Fibroid ◽  
Premature Ovarian Failure ◽  
Uterine Fibroids ◽  
Ovarian Failure ◽  
Embolic Material ◽  
Uterine Fibroid Embolization ◽  
Irregular Period ◽  
Single Centre Study ◽  
Night Sweats

Purpose: To retrospectively determine the incidence of amenorrhea and premature ovarian failure in women who underwent uterine fibroid embolization (UFE) in King Fahad Specialist Hospital in Dammam (KFSH-D). Patients and methods: All women who had undergone UFE in KFSH-D from August 2007 to October 2015 were included for a total of 82 patients. Follow up consisted of a questionnaire inquiring about symptoms, improvement after the procedure and whether menstruation resumed or not. The pre-procedure and post-procedure pelvis MRI as well as UFE images and reports were reviewed for all patients.   Results: One patient (1.5 %) was found to have amenorrhea out of the 67 patients we were able to contact. She was 52 years old at the time of UFE and had irregular period. Menstruation did not resume following UFE along with menopausal symptoms including night sweats, mood swings and irritability, likely due to premature ovarian failure (POF). The rest of patients had normal resumption of menses.  Conclusion: The incidence of amenorrhea is less than what’s reported in the literature could be due to advances in UFE since its introduction as a treatment for uterine fibroids, likely due to advances in image quality, tans-catheter embolization equipments/techniques and embolic material used in UFE.

Sign in / Sign up

Export Citation Format

Share Document